Patient Lift Clip Failures and a 48-Hour Customer Assurance Demand
A manufacturer of mobile patient lifts has received 14 reports in 18 months of the sling attachment clip disengaging under load, out of approximately 62,000 units in service. Two events resulted in patient falls; one caused a distal radius fracture and one a scalp laceration requiring staples. Investigation traced the failures to one production lot of glass-filled nylon clips with a critical dimension of 4.4 mm against a 4.0 plus or minus 0.15 mm specification. Lot traceability shows 9,400 units shipped with the affected clip: 5,600 to 1,200 US facilities, the remainder to Canada and the EU. The defect is not detectable by the user, and the clip is not field-replaceable without a service kit. A large national chain has asked for written assurance within 48 hours that its 300 lifts are unaffected. The next quarterly management review is in 10 days, and the company has no written recall procedure. No regulatory agency has been contacted.
1. Perform a health hazard evaluation and recommend a recall classification with reasoning.
Read the worked answer
Weigh severity, probability, and detectability. Severity: a clip disengaging under load drops a mobility-impaired patient from lift height; the two reported falls caused a fracture and a scalp laceration, and this population includes anticoagulated and frail patients in whom a fall can cause intracranial hemorrhage or death. Probability: 14 reports across 9,400 affected units over 18 months, with underreporting likely because facilities often attribute a dropped patient to caregiver error and do not report near-misses. Detectability: the out-of-specification dimension is not visible and the user cannot inspect for it, so there is no warning before failure. Non-field-replaceable parts with no user check raise risk further.
That combination supports Class II at minimum. Class I should be actively considered if investigation shows a credible pathway to death or serious injury - for example, a progressive crack that releases without warning in a bariatric lift. The classification determines the urgency and wording of the field action, so it should be decided by a documented cross-functional team, not by one manager, and should not be softened to limit publicity.
2. Define the scope of the field action and the traceability steps needed in the next 72 hours.
Read the worked answer
Scope is defined by lot, not by complaint count: all 9,400 units containing the affected clip lot, across the US, Canada, and the EU. Next 72 hours: freeze and quarantine remaining inventory with the suspect lot; query the distribution database to produce a customer-level list with ship dates, serial numbers, and contacts; flag high-acuity users (ICU, bariatric, long-term care) for first contact; issue an immediate stop-use/interim-action notice requiring the lift to be taken out of service until the clip is verified or replaced; prepare a service kit if field replacement is feasible, otherwise a replacement-unit process; and document every lot disposition decision.
For the national chain, answer at serial level. Their 300 lifts either contain the affected lot or they do not - give them a list, not a general assurance. Do not let the 48-hour deadline drive a premature "unaffected" statement that later proves wrong; a wrong assurance converts a recall into a trust and liability crisis.
3. What regulatory notifications and communications are required, and what is the timeline?
Read the worked answer
In the US, a correction or removal undertaken to address a risk to health must be reported to FDA under 21 CFR 806 within 10 working days of initiation; if it is a recall, FDA assigns the class and the firm should prepare for a recall audit and status reports. Medical device reports are required for deaths and serious injuries within 30 calendar days, and within 5 working days when the event is a threat to public health or FDA requests it - the two falls with fracture and laceration should be assessed against the serious-injury definition now, not after the board meeting. In Canada, notify Health Canada under the medical device regulations; in the EU, notify the competent authority in each member state where units were distributed and follow the vigilance procedure.
Communication: direct notification to every consignee stating the lot, hazard, required action, and a response form; a press release only where users cannot be traced, which is not the case here. Keep messages consistent across jurisdictions, separate known facts from hypotheses, and avoid speculative causation. Assign one recall coordinator and a contact log, because regulators will ask for the notification list and return rates.